+

WO2008021970A3 - Traitement d'une maladie des motoneurones, incluant certains troubles neurologiques, des neuropathies motrices et des maladies inflammatoires chroniques - Google Patents

Traitement d'une maladie des motoneurones, incluant certains troubles neurologiques, des neuropathies motrices et des maladies inflammatoires chroniques Download PDF

Info

Publication number
WO2008021970A3
WO2008021970A3 PCT/US2007/075609 US2007075609W WO2008021970A3 WO 2008021970 A3 WO2008021970 A3 WO 2008021970A3 US 2007075609 W US2007075609 W US 2007075609W WO 2008021970 A3 WO2008021970 A3 WO 2008021970A3
Authority
WO
WIPO (PCT)
Prior art keywords
motor
treatment
chronic inflammatory
neuron disease
inflammatory diseases
Prior art date
Application number
PCT/US2007/075609
Other languages
English (en)
Other versions
WO2008021970A2 (fr
Inventor
William K Reid
Original Assignee
William K Reid
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by William K Reid filed Critical William K Reid
Publication of WO2008021970A2 publication Critical patent/WO2008021970A2/fr
Publication of WO2008021970A3 publication Critical patent/WO2008021970A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne un procédé destiné à traiter un patient atteint, ou présentant des symptômes, d'une maladie des motoneurones, d'un trouble neurologique, d'une neuropathie motrice ou d'une maladie inflammatoire chronique. Un mode de réalisation de l'invention inclut un traitement consistant à traiter essentiellement un patient atteint d'une infection fongique, incluant, par exemple, l'administration d'une quantité thérapeutiquement efficace d'un ou de plusieurs agents antifongiques.
PCT/US2007/075609 2006-08-09 2007-08-09 Traitement d'une maladie des motoneurones, incluant certains troubles neurologiques, des neuropathies motrices et des maladies inflammatoires chroniques WO2008021970A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US83638206P 2006-08-09 2006-08-09
US60/836,382 2006-08-09
US91752607P 2007-05-11 2007-05-11
US60/917,526 2007-05-11

Publications (2)

Publication Number Publication Date
WO2008021970A2 WO2008021970A2 (fr) 2008-02-21
WO2008021970A3 true WO2008021970A3 (fr) 2008-11-20

Family

ID=39082970

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/075609 WO2008021970A2 (fr) 2006-08-09 2007-08-09 Traitement d'une maladie des motoneurones, incluant certains troubles neurologiques, des neuropathies motrices et des maladies inflammatoires chroniques

Country Status (1)

Country Link
WO (1) WO2008021970A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5670336B2 (ja) * 2008-10-02 2015-02-18 ユニヴァーシティ オヴ ピッツバーグ オヴ ザ コモンウェルス システム オヴ ハイアー エデュケーション 全身性炎症の治療のためのポリマー吸着剤の投与
AU2009313315A1 (en) * 2008-11-07 2011-06-30 The Cleveland Clinic Foundation Compounds and methods of promoting oligodendrocyte precursor differentiation
US9527815B2 (en) * 2014-06-18 2016-12-27 Biotheryx, Inc. Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating inflammatory, neurodegenerative, or immune-mediated diseases
AU2014403312A1 (en) * 2014-08-04 2017-02-16 Fabrizio De Silvestri Use in single pill/tablet/capsule of minocycline, fluconazole and atorvastatin in the treatment of multiple sclerosis
CA3031818A1 (fr) * 2016-07-27 2018-02-01 Case Western Reserve University Composes et procedes de stimulation de la myelinisation
WO2018112106A1 (fr) * 2016-12-13 2018-06-21 Cove Bio Llc Procédés et compositions de traitement de la maladie de parkinson
KR101854762B1 (ko) 2017-03-10 2018-05-04 순천대학교 산학협력단 알테르나리올 모노메틸 에테르를 유효성분으로 포함하는 우울증 및 불안증의 예방 또는 치료용 조성물
CN109503393B (zh) * 2018-11-07 2021-10-26 江苏省农业科学院 一种高速逆流色谱制备伏马毒素b1标准品的方法
WO2020127059A1 (fr) * 2018-12-17 2020-06-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Utilisation de sulconazole en tant qu'inhibiteur de la furine
CN111760015A (zh) * 2020-01-21 2020-10-13 中南大学 米卡芬净在制备神经保护药物中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050049208A1 (en) * 2003-09-03 2005-03-03 Kaufmann Doug A. Method of treating and method of preventing diabetes
US20060183768A1 (en) * 2004-12-09 2006-08-17 Xention Discovery Ltd. Compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050049208A1 (en) * 2003-09-03 2005-03-03 Kaufmann Doug A. Method of treating and method of preventing diabetes
US20060183768A1 (en) * 2004-12-09 2006-08-17 Xention Discovery Ltd. Compounds

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
BONSMANN ET AL., JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, vol. 44, no. 6, June 2001 (2001-06-01), pages 925 - 931 *
JOHNSON ET AL., AMERICAN FAMILY PHYSICIAN, vol. 61, 1 May 2000 (2000-05-01), pages 2703 - 2710, 2713 - 2714 *
MURRAY J., BRITISH MEDICAL JOURNAL, vol. 325, 2002, pages 1128 *
MYERS ET AL., LEUKEMIA & LYMPHOMA, vol. 44, no. 10, 2003, pages 1827 - 1829 *
PERAICA ET AL., WORLD HEALTH ORGANIZATION, 1999, pages 754 - 766 *
RODRIGUEZ-FERNANDEZ E. ET AL., JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 99, 2005, pages 1558 - 1572 *
STIPA G. ET AL., MEDICAL HYPOTHESES, vol. 67, pages 1363 - 1371, XP005669261 *
UENO Y., CRITICAL REVIEW OF TOXICOLOGY, vol. 4, no. 2, 1985, pages 99 - 132 *
WEBB ET AL., JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 278, no. 27, 4 July 2003 (2003-07-04), pages 25009 - 25013 *

Also Published As

Publication number Publication date
WO2008021970A2 (fr) 2008-02-21

Similar Documents

Publication Publication Date Title
WO2008021970A3 (fr) Traitement d'une maladie des motoneurones, incluant certains troubles neurologiques, des neuropathies motrices et des maladies inflammatoires chroniques
WO2007109749A3 (fr) Procedes de prevention et de traitement des maladies amyloidogenes
WO2007002516A3 (fr) Formes de dosage ameliorees pour le traitement de troubles moteurs
WO2007022470A3 (fr) Methodes et compositions pour le traitement de maladies neurologiques
WO2008050329A3 (fr) NOUVEAUX ARNsi ET PROCÉDÉS D'UTILISATION DE CEUX-CI
WO2007103373A3 (fr) Compositions et procédés pour le traitement de troubles immunoinflammatoires
WO2007076295A3 (fr) Nanoagrégats pour l'administration de substances thérapeutiques
WO2007114903A3 (fr) Traitements à la citrulline
WO2007075592A3 (fr) Substances et procedes de traitement de fibroses chroniques
EP2311433A3 (fr) Procédé pour le traitement de maladies néovasculaires intraoculaires
WO2008029276A8 (fr) Compositions et procédés de traitement d'une maladie ophtalmique
WO2006119884A3 (fr) Methode de traitement de la toxicomanie
WO2005020972A3 (fr) Polytherapie pour le traitement de troubles neovasculaires oculaires
WO2008077092A8 (fr) Effets combinés de topiramate/ondansetrone sur la consommation d'alcool
WO2005076819A3 (fr) Chlorite dans le traitement de maladie neurodegenerative
WO2007089616A3 (fr) Inhibition de l'interaction peptide amyloïde bêta/rage au niveau de la barrière hémato-encéphalique
BRPI0807749A2 (pt) Composto, composição farmacêutica, e, método para a prevenção, tratamento ou melhora de doenças ou condições dérmicas, ou distúrbios de ferida cutânea agudos ou crônicos.
WO2007087457A3 (fr) Polytherapie destinee au traitement de troubles neovasculaires
WO2006098979A3 (fr) Formes posologiques d'aminopterine et methodes pour troubles inflammatoires
WO2008064136A3 (fr) Composés présentant une activité au niveau des récepteurs d'acide rétinoïque
WO2006138372A3 (fr) Procedes et reactifs pour le traitement de troubles inflammatoires
WO2006012641A3 (fr) Procedes de detection et de traitement de troubles auto-immuns
WO2006121995A3 (fr) Methodes de traitement de la nephrolithiase
WO2007047205A8 (fr) Inhibiteurs enzymatiques du pai-1
WO2005079284A3 (fr) Methodes et reactifs pour le traitement de maladies et de troubles lies a des niveaux accrus de cytokines proinflammatoires

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07840826

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC DATED 25.08.2009.

122 Ep: pct application non-entry in european phase

Ref document number: 07840826

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载